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Introduction
Less than 20% of patients with permanent atrial fibrillation(AF) 
spontaneously convert to (sr) after mitral valve surgery.[1],[2] The 
persistence of AF after surgery is associated with a decreased exercise 
tolerance, an increased risk of systemic embolization[3] and higher 
long-term mortality.[4]
Original surgical treatment – (“cut and saw”) -[5] has been 
progressively substituted by other tissue-ablation technologies 
radiofrequency -(RF)- and cryo ablation are the most common. 
Several different lesion sets have been proposed;  including 
pulmonary vein isolation and other left-sided ablation lines, while 
the bi-atrial maze lesion set is less commonly used due to the need 
for right atrial atriotomy and longer times of cardiopulmonary by-
pass.[6] Radiofrequency may be unipolar or bipolar.[7]-[9] The main 
limitation of monopolar catheter is the high probability to not obtain 
transmural lesions in comparison to bipolar probes: moreover the 
latter have a reduced risk of damaging adjacent structures such as the 
esophagus.[10]-[11]
Several studies have reported a high rate of success using 
both monopolar and bipolar RF on rhythm recovery for short 
and intermediate term. Evaluation of long-term effects of these 
procedures has been hampered by several variables. This includes 
clinical characteristics of patients (age, concomitant valve surgery, 
etiology of valve heart disease, left ventricular function, pulmonary 
artery pressure), follow-up strategies and finally the type of energy 
used along with the set of lesions performed. Few studies however 
examined the effects of AF RF ablation along concurrent with mitral 
valve surgery regarding patients’ survival, along their functional 
capacity, and quality of life.[7]
The aim of the present study was to prospectively assess the effects 
of sinus rhythm maintenance on survival after left-sided RF ablation 
of AF along with mitral valve surgery.
Methods
In the study, all patients underwent unipolar or bipolar RF ablation 
along with mitral valve surgery between 1/1/2003 to 12/31/2011 
at the Heart Surgery Department of the Azienda Ospedaliera 
Universitaria of Careggi Hospital in Florence.
The time of onset of AF and functional capacity expressed as 
NYHA(New York Heart Assoc) functional class were recorded 
at hospital admission. Electrocardiogram(ECG) was obtained 
examination was performed to confirm the presence of arrhythmia. 
All patients underwent transthoracic echocardiography with a 2.5 
and 3.5 MHz probe (Sequoia C256 Accuson Siemens Mount View, 
California). Left atrium AP diameter (mm), 2D left and right 
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Abstract
Background: The usefulness of radiofrequency (RF) ablation in restoring sinus rhythm in patients with permanent atrial fibrillation (AF) 
undergoing surgery for mitral valve has been demonstrated. But whether sinus rhythm recovery affects long-term survival is Less Clear.  
Methods: This study included 301 consecutive patients (126 men and 175 women, age 69±6 years) undergoing radiofrequency ablation 
of persistent atrial fibrillation along with mitral valve surgery. Radiofrequency ablation was performed using unipolar probe in 55.3%, bipolar 
probe in the remaining 44.7% of cases. 
Results: Four patients died during hospitalization. At follow-up, sinus rhythm was present in 76% of the surviving patients. 71 patients 
never recovered sinus rhythm after hospital discharge. Mortality and recurrent hospitalization were significantly lower in patients with sinus 
rhythm at the end of follow-up in comparison to permanent AF. The incidence of stroke was also lower in patients with stable sinus rhythm. 
Larger atria, pulmonary hypertension and history of rheumatic disease were associated with the persistence of AF despite radiofrequency 
ablation. Although survival and functional capacity were significantly lower in patients with permanent AF at multivariate analysis only age 
and pulmonary artery pressure before surgery were independently associated with mortality.
Conclusions: Sinus rhythm restoration by RF ablation in patients undergoing mitral valve surgery is associated with an improved long-term 
survival. However our results suggest that a more severe hemodynamic impairment, expressed by higher pulmonary artery pressure, and 
increasing age are the only independent factors related to long-term survival.
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atrial area (cm2) and left ventricular ejection fraction (LVEF) were 
measured. End-diastolic and end-systolic images were synchronized 
on ECG. Since patients were in AF we considered the average 
value of five measurements. Pulmonary systolic pressure (PAP) was 
calculated adding tricuspid valve pressure gradient to estimated right 
atrial pressure assessed by inferior vena cava diameter and response 
to respiration.
Ablation technique
  Medtronic Cardioablate surgical ablation systems (Medtronic, 
Minneapolis USA) were used for monopolar and bipolar treatment. 
Detailed description of left sided ablation lines has been previously 
reported.[12] The extra time on cardiopulmonary by-pass for ablation 
was on average 15±8 min.
Post-operative management 
   To favor maintenance of sinus rhythm after RF ablations 
amiodarone bolus of 300 mg was administered i.v. followed by a 
continuous infusion of 1,200 mg in the first 24 hours; thereafter 
it was prescribed 200 mg orally every 12 hours until discharge. A 
maintenance regimen of 200 mg/day was prescribed for 3 months. 
Patients with persistent AF after RF ablation underwent at least 
one attempt of external cardioversion by biphasic DC-shock. Oral 
anticoagulation was given to maintain the International Normalized 
Ratio(INR) between 2.5 and 3.5 for the first 6 months in all patients, 
and life-long in patients who received mechanical valves or who had 
persistent AF or both.
Follow-up
   Patients were seen at the outpatient clinic 3 months, 6 months, 
and 12 months after the surgical procedure and annually thereafter. 
Between visits, their referring physician attended patients on a 
regular basis and routine ECGs were obtained at each clinic visit 
regardless of symptoms. Event monitors were prescribed for patients 
who complained of palpitations or symptoms compatible with AF 
during follow-up. Between visits, all patients were encouraged to seek 
12-lead ECG documentation for any symptom suggestive of AF/
atrial flutter recurrence and a physician routinely performed trans-
telephonic monitoring of any symptoms and complications.
   The follow-up evaluation consisted of a detailed history, physical 
examination and 24-h Holter monitoring. Success and AF recurrence 
were defined as per the HRS/EHRA/ECAS expert consensus 
document.[13] Informed consent was obtained by all patients and the 
study approved by the Ethical Committee of our Institution.
Statistical analysis 
   Data are presented as means ± SD for continuous variables and 
Table 1: Clinical characteristics of patients
Gender  (M/F) 126/175
Age  (years) 69.1 ± 49.7 
Preoperative AF duration (months) 36.9 ± 49.7
LVEF   (%) 51.6 ± 9.8
LA (mm) 53.7 ± 8
LA area  (cm2) 32.5 ± 10
RA area  (cm2) 22.3 ± 6.7
Systolic Pulmonary 
pressure (mmHg)
44.2 ± 14.9
  NYHA class 2.9 ± 0.6
AF= atrial fibrillation, LVEF = left ventricular ejection fraction, LA = left atrium, RA = right atrium 
Table 2: Etiology of mitral regurgitation
%
Mitral valve  prolapse 26.3
Rheumatic mitral valve disease 28.7
Rheumatic mitral-aortic  valve disease 19
Ischemic mitral regurgitation 12.7
DCMP related mitral regurgitation 2
DCMP – dilated cardiomyopathy
Table 3: Type of intervention performed
%
Mechanical MVR 12.7
Biologic MVR 13.7
Mitral  valve repair 30
MVR / mitral valve repair and AVR 18.7
Mitral valve repair and  CABG 10.3
MVR and  CABG 4.3
DCMP related mitral regurgitation 10.3
MVR – mitral valve replacement , AVR- aortic valve replacement CABG -coronary artery by-pass 
graft
as percentages for categorical variables. Continuous variables were 
compared through the use of Student’s 2 tailed unpaired-sample 
test. Categorical variables were compared using the chi-square test 
or Fisher’s exact test if appropriate. Differences among groups were 
evaluated using ANOVA test. Multivariate analysis was performed 
using stepwise Cox regression method. Kaplan-Meier curves were 
used for the survival analysis. Differences between groups were 
compared using Log-Rank test. A probability value < 0.05 was 
considered significant. Statistical analysis was performed using SPSS 
22.0 software (SPSS, Inc., Chicago, IL, USA). 
Results
 In the period under investigation 301 patients, 126 men 
and 175 women, mean age of 69.1 ± 9.7 years underwent RF 
Figure 1: Kaplan Meyer survival curves of patients treated with monopolar and bipolar RF ablation
ablation in conjcution with mitral valve surgery. The clinical and 
echocardiographic characteristics are reported in [Table 1]. Four 
patients died in the immediate postoperative period (1.2%). One 
patient died of a cerebral hemorrhage, one of myocardial infarction, 
the remaining 2 of septic shock. 297 patients were included in the 
study. At the time of surgery 80% patients had severe functional 
impairment (III-IV NYHA class). Rheumatic mitral valve disease, 
lone or combined with aortic valve disease, (47.7%), and mitral valve 
prolapse were the more frequent indication to surgery [Table 2]. 
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Details on surgical interventions performed are reported in [Table 
3]. Radiofrequency ablation was performed using catheter unipolar 
probe in 55.3%, and bipolar in the remaining 44.7% of cases. There 
were no significant differences between clinical characteristics of the 
two groups except for age and left atrial LA diameter [Table 4].
Rhythm analysis 
   At the end of follow-up 69.4% patients were alive. Among them 
76% were in sinus rhythm at the last follow-up visit. During follow 
up (mean duration about 8 years) 40.9% of patients remained in 
sinus rhythm at periodic clinical examinations and never experienced 
clinically demonstrated recurrent AF. 9 patients discharged in AF 
were in sinus rhythm at the end of follow up. One hundred and three 
patients (35.2%) had at least one symptomatic AF episode during 
follow-up. Finally 24% had permanent AF despite radiofrequency 
treatment and electrical CV attempts. Atrial tachycardia, was 
recorded in 6.9%. twenty-seven patients underwent definitive pacing, 
8 during hospitalization, 19 during the follow-up period. The clinical 
and echocardiographic characteristics before surgery of the three 
groups of patients (stable sinus rhythm, recurrent AF, persistent AF) 
are shown in [Table 5]. Patients with persistent AF despite treatment 
were on average older, by uprox 3 years, compared to those than those 
with recurrent AF or who remained in stable sinus rhythm (p=0.03).
We did not find any relationship between rhythm at follow-up 
regarding gender, surgical procedure performed, permanent pacing, 
left ventricular ejection fraction(LVEF) and finally NHYA class 
before surgery. Left atrium diameter, left and right atrial area were 
significantly lower in patients with stable sinus rhythm in comparison 
with the other two groups. Systolic pulmonary artery pressure was 
higher in those are with persistent AF than in those with stable sinus 
rhythm. Logistic multivariate analysis showed that the duration 
of the arrhythmia (OR 1.005 95%CI 1.00019 -1.01074 p= 0.04) 
, preoperative left atrial area size(OR 1.03874 95%CI 1.00537-
1.07321 p= 0.02) , tricuspid valve repair (OR 2.07273 95%CI 
1.07453-3.99821 p=0.03) and attempts to DC cardiovert(OR 1.9163 
95%CI 1.00933 -3.63854 p= 0.04) were associated with permanent 
atrial fibrillation.  
Other outcome
Ischemic stroke occurred in 8 of patients (3%) during follow-up. 
Among the 6 who were in permanent AF, 5 had INR values at stroke 
occurrence below the therapeutic range. Significant carotid stenosis 
was found in 1of the 2 patients in SR.
Hospitalization due to cardiac cause during the follow-up period 
was needed in 31% of patients. The hospitalization rate was almost 
twofold in patients who never regained sinus rhythm after ablation 
in comparison with patients in sinus rhythm(SR) at the end of 
follow-up. The high hospitalization rate in patients with recurrent 
AF was mainly related to attempts of SR restoration. A significant 
Table 4: Clinical characteristics of patients treated with monopolar or bipolar RF ablation
Monopolar Bipolar p
169 132
Age (years) 67.8+9 70.7+9.0 0.019
Sex M/F 99/70 76/56 0.9
Duration AF 38+43 35+56 0.55
SR at follow-up % 100/69 74/58 0.63
LVEF (%) 52+10 51+9 0.63
LA (mm) 49+6 53+8 0.001
LA area (cm2) 32+10 32+9 0.8
RA area (cm2) 22+6 22+6 0.8
Syst Pulmonary
pressure (mmHg)
44+15 42+14 0.5
Etiology
Mitral valve prolapse 48 31 0.06
Rheum MVD 57 29
Rheum MAVD 25 32
Ischemic MR 20 18
Dilated Cardiomiopathy 19 22
NHYA class
I 0 1 0.05
II 28 40
III 117 78
IV 24 13
SR- sinus rhythm , LVEF = left ventricular ejection fraction, LA = left atrium, RA = right atrium , 
MVD= mitral valve disease, MAVD= mitro-aortic valve disease, MR= mitral regurgitation
Table 5: Clinical characteristics of different groups
Stable SR AF recurrence Permanent 
AF
P
Age (years) 67.7 + 9.2 67.9 + 10 71.9 + 8.5 0.0494
LA (mm) 50.7 + 7.1 53.9 + 8.7 56.1 + 8.4 <0.0001
LA area (cm2) 30.7 + 7.8 32.1 + 8.0 37 + 11.4 <0.0001
RA area (cm2) 20.4 + 4.0 21.9 + 6.0 23.9 + 6.8 0.0159
Systolic
PAP (mmHg)
41.0 + 11.9 44.4 + 14.1 46.1 + 15.4 <0.0001
Electric cardiovesion
before discharge (%)
9.1 20.1 28.9 0.0092
Hospitalization (%) 17.5 48.8 30.0 <0.0001
AF= atrial fibrillation, LVEF = left ventricular ejection fraction, LA = left atrium, RA = right atrium
improvement in functional capacity was found after surgery.
Survival analysis
 At the end of follow-up period overall survival was of 85.7%. 
Forty-three patients died during follow-up, 67.4% due to cardiac 
causes. Patients who died were older than survivors (mean age 72.9 
± 6,2 vs. 68.6 ± 9.4 years, p 0.026). We did not find gender related 
differences in mortality, there was no difference in mortality between 
patients who underwent monopolar or bipolar radiofrequency 
ablation [Figure 1].
    Overall mortality was significantly higher in patients with persistent 
AF in comparison to those in stable sinus rhythm after discharge (Log 
Rank test-p=0.009). The survival rate however was not significantly 
different in patients with stable sinus rhythm during follow-up in 
comparison to patients who had transient AF recurrences but were 
in sinus rhythm at the end of follow-up [Figure 2].
    Long-term mortality was higher in patients with rheumatic mitral 
valve disease who had a lower probability of sinus rhythm recovery, 
than in those suffering from mitral valve prolapse. Tricuspid valve 
repair was associated to a worse prognosis: it was performed in 28.6% 
patients who died in comparison to 14.8% survived at the end of 
follow-up (p=0.041).
   Preoperative functional capacity was not related to survival. The 
percentage of patients in advanced NYHA class (III-IV) was not 
significantly different in the two groups (82% of survivors vs. 91% 
of deceased patients). Atrial size (both right p=0.0023 and left atrial 
area p=0,0135) and pulmonary artery pressure (43.3 ± 14.3 vs 49.3 ± 
17.2 mmHg; p=0.022) were significantly lower in survived patients.
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with permanent atrial fibrillation (AF) undergoing surgery for mitral 
valve disease. 
In a retrospective study an improved survival rate was reported in 
the subgroup of 65 patients treated with the maze procedure (SR at 
81% at 5 years) in comparison with patients who underwent isolated 
mitral valve repair.[20] Ad et al[21] reported a higher four-year survival 
in patients who underwent Cox-maze procedure versus patients with 
untreated AF (OR= 2.47; P = 0.048).
At present this study is the largest with a long follow-up evaluating 
the relationship between RF ablation with mitral valve surgery 
and mortality. Survival rate is significantly lower in patients with 
permanent AF after surgery, in comparison with patients with 
stable sinus rhythm and in whom at least 1 recurrence of AF was 
documented during follow-up (70% vs respectively 90 and 91%). 
Factors associated with mortality were also related to an increased 
rate of persistent AF at follow-up. Only age and pulmonary artery 
pressure before surgery were independently associated with survival.
Limitation of the study
The absence of a control group is a limitation of the study. Few 
clinical studies in literature compared the results of concomitant AF 
ablation in open heart surgery with those of a concurrent control arm 
(that is leaving the AF untreated). The absence of a control arm does 
not allow to assess the absolute effect of the ablative procedure either 
because it is impossible to know how many of the patients would 
convert to sinus rhythm spontaneously and more relevant; the effects 
of confounding variables (e.g. the different degree of hemodynamic 
impairment).
The results of 7 matched-controlled and 4 randomized trials of 
the maze procedure associated with concomitant mitral valve surgery 
showed that freedom from AF was 77% to 95% in the maze group 
versus 4% to 53% in the control group at 2 and 8 year follow-up.[22]
The study by Gillinov et al[23] randomized to surgical ablation or no 
ablation 260 patients w ith persistent or long standing persistent AF 
undergoing mitral valve surgery. Sinus rhythm was present in 63.2 % 
in the ablation group in comparison to 29.4 % (p<0.0001) in the non-
ablation group. Ablation was associated with a higher risk of pace-
maker implantation and no significant differences were reported in 
major cardiovascular or cerebrovascular adverse effects. The effects 
on survival are not valuable due to brief duration of follow-up (1 
year). Another possible limitation related to the lesion set as this 
study involved only the left atrium. No randomized studies, however, 
have compared different RF lesion sets. In their study Gillinov et 
al[23] reported no significant difference after surgical pulmonary vein 
   At multivariate analysis, only age (OR= 1.1; 95% CI= 1.02-1.11; 
p= 0.003) and pulmonary artery pressure (OR=1.03; 95% CI= 1.02-
1,12; p= 0.02) were independently associated with survival [Figure 
3].
Discussion
Radiofrequency ablation along with mitral valve surgery has been 
reported to significantly affect rate of sinus rhythm recovery however 
the characteristics of the population included in each study and the use 
of different RF catheters (unipolar or bipolar) and ablation line sets 
Table 6: Clinical characteristics of survived and died patients
Survived Died p
Preoperative AF duration (months) 36.5 + 50 39.4 + 48.3 0.72
AF recurrence free  (days) 759 + 831.5 293 + 575 0.0001
LVEF (%) 59 + 9.5 49.9 + 12.1 0.22
LA (mm) 53.4 + 27 56 + 91 0.06
LA area (cm2) 31.1 + 7.9 36.3 + 18.7 0.0135
RA area (cm2) 21.9 + 5.7 24.5 + 10.7 0.0328
Syst Pulmonary
pressure (mmHg)
43.3 + 14.3 49.3 + 17.2 0.022
AF= atrial fibrillation, LVEF = left ventricular ejection fraction, LA = left atrium, RA = right atrium
Figure 2: Kaplan Meyer survival curves : comparison among patients with stable sinus rhythm, recurrences of AF and persistent AF
may account for the large differences in success percentage observed.
[14]-[17] Moreover results may have been influenced by the absence of a 
uniform AF classification, adequate reporting of preoperative cardiac 
conditions or by the different methods of evaluating AF recurrences.
In our study we followed the HRS/ EHRA/ECAS expert 
consensus document to evaluate the success of the procedure.[13]
In previous studies preoperative LA size, cardiothoracic ratio 
over 60%, fine AF wave at preoperative ECG, and no early sinus 
rhythm restoration, an increasing number of concomitant surgeries 
were reported as independent predictors of ablation failure in the 
intermediate follow-up period at multivariate analysis.[14]-[16],[18]
An elevated mean-age of patients, the absence of paroxysmal AF and 
a high percentage of rheumatic valve disease may explain the relative 
high rate (26%) of persistence of AF at hospital discharge observed 
in present investigation. Atrial fibrosis[19] may be responsible for the 
poor results of RF ablation in rheumatic heart disease. Duration of 
the arrhythmia, preoperative left atrial area, tricuspid valve repair and 
finally in hospital attempt of DC cardioversion were independently 
associated with persistence of AF.
Few studies evaluated the effects on long term survival of sinus 
rhythm maintenance after radiofrequency (RF) ablation in patients 
Figure 3: Results of multivariate logistic analysis on survival
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K, MackMichael J, AckerMichael A, MullenJohn C, RoseEric A, ChangHelena 
L, PuskasJohn D, CoudercJean-Philippe, GardnerTimothy J, VargheseRobin, 
HorvathKeith A, BollingSteven F, MichlerRobert E, GellerNancy L, 
isolation alone or bi-atrial maze procedure in sinus rhythm rate at 1 
year (61 vs 66%).
Patients included had long lasting AF before surgery and in patients 
discharged in AF late recovery of sinus rhythm occurred only in 9. 
Moreover on average AF recurrence occurred 750 days after surgery, 
a time significantly longer than standard “blanking period”.
Conclusions
   The present study supports the efficacy of RF ablation (unipolar 
and bipolar) in restoring SR in patients with AF undergoing mitral 
valve surgery and demonstrates that, in patients in whom sinus 
rhythm is maintained after RF ablation, not only the quality of life 
is improved but mortality is also significantly decreased. However 
our results suggest that a more severe hemodynamic impairment, 
expressed by higher pulmonary artery pressure, and increasing age 
are the only independent factors related to long-term survival.
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